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Bovine viral diarrhoea (BVD) is a viral disease appearing in various forms 
and causing high economic losses in the cattle stocks of Hungary. The aim of the 
present study was to determine the prevalence of bovine viral diarrhoea virus 
(BVDV) in Hungary through a monitoring survey carried out on samples col-
lected in cattle-keeping units throughout the country. Since no such survey had 
been carried out in Hungary during the last thirty years, our study may serve as a 
basis for later monitoring investigations aimed at following the progress of an ex-
pected eradication campaign of BVD. The tests were carried out using an ELISA 
method, on a total of 1200 blood samples submitted from 54 cattle herds. The 
herds had not been vaccinated against BVDV before the sampling. Out of the 
1200 samples, 521 proved to be positive (43.4%), 40 gave doubtful result (3.3%) 
and 639 were negative (53.3%). In some stocks the samples were collected from 
cows having completed several lactation periods, and therefore the seronegativity 
indicates the BVDV-free status of the given stock. Moreover, among the positive 
herds we found a few where the seropositivity rate was rather low (< 5%). Ac-
cording to the results of the survey, a rather high portion (about one third) of the 
cattle-keeping units of Hungary can be regarded as BVDV free, which ratio is 
much higher than had been expected on the basis of surveys carried out on a 
lower number of samples and in smaller regions of the country. Hence, the 
chances of an eradication campaign launched in the near future, or carried out 
parallel to the IBR eradication programme, are better than previously expected.  
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Due to the special features of the infection, bovine viral diarrhoea (BVD) 
is one of the leading health problems of cattle in most European countries where 
it is present. Infection with the virus can cause several diseases ranging from 
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subclinical infection and seroconversion to fatal mucosal disease, and including 
peracute diarrhoea and reproductive failure. Besides being a source of direct 
losses by causing enteritis in calves (as reflected in the name of the disease), bo-
vine viral diarrhoea virus (BVDV) also has a fetopathic ability, hence reducing 
the reproductive capacity of a herd. 
BVDV is a single-stranded RNA virus that belongs to the Pestivirus genus 
of the Flaviviridae family. It has two biotypes: cytopathic (CP) and non-cytopathic 
(NCP). If the non-cytopathic type crosses the placenta to enter the fetus, the 
newborn calf will be persistently infected (PI) post partum, and these animals are 
critical to the spread of the virus, since they are a major source of infection in a 
herd shedding the virus in large amounts in their secretions and excretions, caus-
ing seroconversion in healthy herdmates and reproductive failure in pregnant cows. 
The virus may also be spread by biting insects, fomites (enabling iatrogenic 
transmission), semen (highly important in farms using assisted reproduction), 
contact with other animals and potentially by discharges from the reproductive 
tract of infected cows. A PI female remaining clinically normal for many breed-
ing seasons can produce PI lineage continuing for several generations, which will 
shed the virus indefinitely (Radostits and Done, 2007; Kahn and Line, 2010). 
The cytopathic strain is most dangerous when it enters a PI animal, result-
ing in mucosal disease (MD). CP is a mutant of the NCP strain within PI animals 
(Goens, 2002). 
In addition to strain classification, antigen diversity divides the virus into 
BVDV types 1 and 2, with BVDV-1 comprising many important subgenotypes. 
The single European market presents an opportunity for a serotype matrix to oc-
cur across Europe and present a major problem for vaccination and surveillance 
for the virus (Graham et al., 2001; Hamers et al., 2001). 
The costs incurred by farms raising suckler herds infected with BVDV are 
due to abortion, congenital defects, stillbirths, increased neonatal mortality, re-
duced immunocompetence, growth retardation, reproductive disorders, early dis-
posal of PI animals, and deaths from mucosal disease (Radostits and Done, 2007). 
The cost of infection depends on statistical weighting towards a given dis-
ease impact, e.g. production/efficiency or animal welfare. Quantitative analysis 
of BVDV relies almost entirely on economic aspects, overlooking the impact of 
animal welfare, e.g. pain and stress, and their impact on feed conversion ratios 
(Lindberg and Alenius, 1999). 
Since in Hungary, before this study, no overall representative surveys had 
been carried out to establish the prevalence rate of BVDV, we planned to carry 
out a serosurvey using blood samples from different large-scale farms throughout 
the country. We decided to use the indirect method (serology) to demonstrate the 
presence of the virus in a certain stock, because antibodies persist longer and 
give more informative results on prevalence of the virus. Our data are aimed to 
help eradication of the virus, which has already been started in some stocks on a 
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voluntary basis. We wanted to know if there were any non-infected stocks, which 
might serve as ‘nucleus stocks’ to provide virus-free animals to replace heavily 
infected stocks in which the high seropositivity rate indicates active circulation 
of BVDV. Therefore, we were interested in the prevalence of the virus more on 
herd level than on the level of individual animals. 
Published European surveys for determining the herd-level prevalence of 
BVDV infection are usually based on samples of bulk milk or those taken from tar-
geted age groups (spot samples). For countries that have implemented systematic 
control, Tables 1 and 2 include surveys performed before or at the beginning of the 
schemes (Greiser-Wilke et al., 2003; Vilcek et al., 2003; Hagglund et al., 2006; Gul-
liksen et al., 2009; Ridpath, 2010). 
Table 1 
BVD control status in some countries of Europe (data are not available from all countries) 
Antibody prevalence 
Country Period 
Herd level (%) Animal level (%) 
Belgium  100 65.50 
Denmark 1988 100 64.40 
Germany 1993–1994   
Lithuania 1997–2001 70.10 58.20 
Poland   86 (bulls at artificial  
insemination centres) 
Slovakia 2000 100 69 
Switzerland 2010  1.1 
United Kingdom 1985–1986  64.90 
Sweden 1991 91 (bulk milk samples)  
Sweden 2006 38 (bulk milk samples)  
Table 2 
BVD seropositivity and antigen prevalence in some countries of Europe (data are not available 
from all countries) 
Country Period Herd antibody  prevalence (%) 
Herd virus/Active infection 
prevalence* (%) 
Austria 1996–1998  1 
Denmark 1994  39 
Estonia 1993–1995, 1997–1998, 
1999–2000 
 46, 16,  
18 
Finland 1993 1  
England and Wales 1996 95.40 65.50 
Northern Ireland 1999 99 49.60 
Norway 1993 37 7.10 
Sweden 1993  51 
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Materials and methods 
Herds. The sample population was diverse geographically (see Fig. 1) and 
in terms of the age, sex and purpose of the animals: Sera for analysis were taken 
from calves, heifers, cows and bulls from 54 herds throughout Hungary. Some 
farms owned herds at multiple premises sampled in the study. None of the herds 
applied vaccination against BVD. 
 
Fig. 1. Geographical distribution of the herds sampled (the north-western part of Hungary is 
enlarged because the herds were too close to each other) 
 
Blood samples. Blood samples were obtained via jugular venipuncture and 
allowed to clot. Serum was isolated via centrifugation at 1000 g for 3 min, re-
moved from the samples and stored at –20 °C until analysis. 
Serological tests. BVD antibodies were identified in the sera using an 
ELISA test kit (IDEXX HerdChek BVDV Antibody Test Kit, IDEXX Laborato-
ries Inc., Westbrook, ME, USA) according the manufacturer’s instructions. 
 
 
Results 
The abridged results of the survey are shown in Table 3, with herds 
grouped according to disease prevalence. The cumulative results of the survey 
are presented in Table 4. 
Group 1. Herds of this subset may be classified as truly seropositive for 
BVD. Total or near-total seropositivity was exhibited. These are ‘problem herds’ 
which would benefit from the implementation of an eradication strategy. In 
farms where age data reveal that all positive animals were cows, these animals 
may be descendants of animals that were exposed to a PI animal. The disease 
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will perpetuate in these farms unless all infected stock is replaced. It is also pos-
sible that such farms used a live attenuated vaccine in the past and that this vac-
cine strain causes antibody generation in subsequent offspring. It is reported that 
such a strain was widely used in Hungary in the 1990s, resulting in rapid spread 
of the disease through herds, since it was demonstrated that live vaccine virus 
can cross the placenta (Orban et al., 1983). Pregnant animals vaccinated during 
this period were also affected, with those vaccinated in the first half of gestation 
transmitting the virus to their offspring. This resulted in the birth of very high 
numbers of PI animals. Other explanations include vaccination without docu-
mentation, vaccination when under the care of another veterinarian and not in-
forming the current veterinarian of vaccination status, seropositive semen (im-
possible as all semen is screened for BVD), or seropositive bull. 
Group 2. This cohort showed variable rates of disease throughout various 
herds and geographical regions. It is possible that these animals have PI offspring 
each year which propagate the disease through other calves. Also, these farms 
may have purchased infected animals or have some breeding animals that were 
exposed to the disease at various stages of gestation. 
Group 3. These herds display very low seropositivity: one individual test-
ing positive or questionable. In a sample size of 1200 animals, this low preva-
lence may be interpreted as test error as it is within the ELISA error range. These 
herds should be retested to increase the reliability of their data. 
Group 4. The results from these herds can be regarded as statistically invalid 
due to lack of data and a sample size of low statistical validity. The results may 
be accurate for the individual herd but are discounted from the study as their in-
clusion would induce artificially seronegative skewed herd-level seroprevalence. 
Group 5. BVD-free status in these herds is highly probable. Large popula-
tions were sampled but no age data were recorded, which reduces the degree of 
certainty with which results can be analysed. 
Group 6. The animals sampled in this group were of sufficient age to have 
been exposed to the virus if it had been present in their environment for a clini-
cally significant time period. In addition, the sample sizes at these locations were 
large enough to provide statistical validity and thus these farms could conclu-
sively be branded ‘BVD-free’. 
 
Discussion 
Considering BVDV a production-limiting disease (in the same manner as 
Johne’s disease, neosporosis or enzootic bovine leukosis), the losses caused by it 
can be described as direct production losses (reduced milk yield on dairy farms, 
reduced slaughter value of beef cattle, abortion and reproductive losses) and 
treatment costs (veterinary and medication costs, increased labour demands) (Chi 
et al., 2002). 
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Losses from BVDV outbreaks concomitant with other diseases or due to 
high mortality caused by a BVDV strain can be in excess of €340 per cow in the 
outbreak herd (Houe, 2003). For beef herds a mean loss of €54 per cow and per 
year has been calculated. In the United Kingdom, Denmark and Norway, where 
the disease is endemic, national losses at population level are estimated to be be-
tween €8.5 and €34 per calving (Houe, 1999). Additionally, in Scotland BVD 
outbreak losses (estimated at £37 per cow) are compounded by the loss of pre-
miums awarded to herds with BVD-free status (Gunn et al., 2004). The eco-
nomic losses caused by BVDV infection on herd and national level are estimated 
to be high (Ózsvári et al., 2001; Majer et al., 2014). 
The BVDV surveillance, control and eradication measures used in other 
European countries are influential in shaping Hungary’s own BVDV strategy 
(Szabára and Ózsvári, 2013). Vaccination against the virus has questionable effi-
cacy in preventing fetal infection, as the birth of PI calves has been demonstrated 
in vaccinated herds. Researchers have shown that because 100% efficacy is re-
quired to prevent infection when a herd is exposed to the disease, vaccination 
does not reduce the prevalence or incidence of BVDV (Lindberg et al., 2006). In 
preventing macro- and microeconomic losses due to the virus, eradication and 
control are more effective than the prevention of clinical signs by vaccination 
(Brock, 2004). Prevention of the disease in infected animals is ineffective in con-
trolling transmission. Therefore, the most effective means of reducing the threat of 
BVDV is an eradication programme. Persistently infected animals must be elimi-
nated to prevent fetal infection (Lindberg and Alenius, 1999; Ridpath, 2010). 
Our results suggest that the seropositivity rate on individual level is 43.4% 
(521 seropositive animals from 1200 sampled). If we compare this level to other 
countries, we find that it is higher then it had been in the Scandinavian countries 
prior launching the eradication campaign, but lower then it was in certain regions 
of Austria or Denmark (Greiser-Wilke et al., 2003).  
The calculation of seropositivity on herd level shows that 29.6% of the in-
vestigated farms (16 out of 54 farms) were not infected (Table 4). The ratio of 
seronegative farms is important, since these herds may serve as sources of ani-
mal replacement, because during an eradication programme only animals from 
BVD-free stocks can be introduced to farms where the programme has started. 
Hence, completely seronegative herds should be used as market seeds. The pro-
prietors of these herds can demand higher premiums for their stock as sales come 
without the risk of BVD propagation. The monetary value of the herd is enhanced 
by BVD-free status as various countries among Hungary’s neighbours screen for 
BVD when importing stock. Seronegativity guarantees export to these countries, 
which is particularly valuable for farmers wishing to establish such trade links. 
Furthermore, there are quite a few positive herds (11.1%) where the sero-
positivity rate is extremely low (one out of 15–20 samples is positive or ques-
tionable), which either means that the test result could be false and the test has to 
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be repeated (especially if the OD value was close to the positivity margin) or the 
virus is freshly introduced into the stock. In these herds, identification and selec-
tion of PI animals may be carried out (by PCR from peripheral lymphocytes or 
by Ag ELISA from ear notches), and the removal of PI animals may result in 
successful eradication of BVD from the herd. 
The age of the tested animals should also be taken into consideration. The 
older the tested animals, the more reliable the data are. Cows had more time to get 
the infection than 6–8 months old calves. Therefore, if the sera of the cows are 
negative, the herd is most probably negative, too. In farms where age data reveal 
that all positive animals were cows, these animals may be descendants of animals 
that had been exposed to a PI animal. The infection will perpetuate in these farms 
unless all infected stock is replaced. It is also possible that such farms used a live 
attenuated vaccine in the past and that this vaccine virus strain caused antibody 
generation in subsequent offspring. Such a strain was widely used in Hungary in the 
1990s to successfully prevent the clinical symptoms of the disease in the herds, but 
if pregnant animals were vaccinated in the first half of gestation, they transmitted the 
virus to their offspring. This resulted in the birth of very high numbers of PI animals. 
If the seropositivity rate is very high within a herd, then eradication by the 
test and cull method is not possible. In this case only total replacement of the 
stock can be effective, or the calves should be separated from the cows as soon 
as possible, tested for their PI status (from ear notches) and raised on a separate 
farm. The heifers raised in this new, separated stock should not be mixed to the 
cows. This is possible if a farm has more than one location. 
Farms in which multiple premises were tested and the results showed sub-
sets of seropositivity and seronegativity should designate the seronegative herds 
as breeding stock. Using offspring from these herds will allow the farm to phase 
out BVD completely without having to pay higher prices for guaranteed BVD-
free stock. Such farms must also prevent exposure to disease by purchasing ani-
mals only from other BVD-free herds and not allowing their animals to mix with 
those of undefined or BVD-positive herd status. 
BVD-free herds must prioritise protection of their status. This requires the 
design of disease prevention protocols ideally including breeding, animal pur-
chase and stock replacement, as well as herd and operator hygiene policies 
(Laureyns et al., 2010). 
 
References 
Brock, K. V. (2004): Strategies for the control and prevention of bovine viral diarrhea virus. Vet. 
Clin. North Am. Food Anim. Pract. 20, 171–180. 
Chi, J., VanLeeuwen, J. A., Weersink, A. and Keefe, G. P. (2002): Direct production losses and 
treatment costs from bovine viral diarrhoea virus, bovine leukosis virus, Mycobacterium 
avium subspecies paratuberculosis, and Neospora caninum. Prev. Vet. Med. 55, 137–153. 
Goens, S. D. (2002): The evolution of bovine viral diarrhea: a review. Can. Vet. J. 43, 946–954. 
 SEROPREVALENCE OF BOVINE VIRAL DIARRHOEA VIRUS IN HUNGARY  263 
Acta Veterinaria Hungarica 63, 2015 
Graham, D. A., McLaren, I. E., Brittain, D. and O’Reilly, P. J. (2001): Genetic typing of ruminant pesti-
virus strains from Northern Ireland and the Republic of Ireland. Res. Vet. Sci. 71, 127–134. 
Greiser-Wilke, I., Grummer, B. and Moennig, V. (2003): Bovine viral diarrhoea eradication and 
control programmes in Europe. Biologicals 31, 113–118. 
Gulliksen, S. M., Jor, E., Lie, K. I., Loken, T., Akerstedt, J. and Osteras, O. (2009): Respiratory in-
fections in Norwegian dairy calves. J. Dairy Sci. 92, 5139–5146. 
Gunn, G. J., Stott, A. W. and Humphry, R. W. (2004): Modelling and costing BVD outbreaks in 
beef herds. Vet. J. 167, 143–149. 
Hagglund, S., Svensson, C., Emanuelson, U., Valarcher, J. F. and Alenius, S. (2006): Dynamics of 
virus infections involved in the bovine respiratory disease complex in Swedish dairy herds. 
Vet. J. 172, 320–328. 
Hamers, C., Dehan, P., Couvreur, B., Letellier, C., Kerkhofs, P. and Pastoret, P. P. (2001): Diver-
sity among bovine pestiviruses. Vet. J. 161, 112–122. 
Houe, H. (1999): Epidemiological features and economical importance of bovine virus diarrhoea 
virus (BVDV) infections. Vet. Microbiol. 64, 89–107. 
Houe, H. (2003): Economic impact of BVDV infection in dairies. Biologicals 31, 137–143. 
Kahn, C. M. and Line, S. (2010): The Merck Veterinary Manual. Merck & Co. Inc., Whitehouse 
Station, N. J. 
Laureyns, J., Ribbens, S. and de Kruif, A. (2010): Control of bovine virus diarrhoea at the herd 
level: Reducing the risk of false negatives in the detection of persistently infected cattle. 
Vet. J. 184, 21–26. 
Lindberg, A. L. E. and Alenius, S. (1999): Principles for eradication of bovine viral diarrhoea virus 
(BVDV) infections in cattle populations. Vet. Microbiol. 64, 197–222. 
Lindberg, A., Brownlie, J., Gunn, G. J., Houe, H., Moennig, V., Saatkamp, H. W., Sandvik, T. and 
Valle, P. S. (2006): The control of bovine viral diarrhoea virus in Europe: today and in the 
future. Rev. Sci. Tech. Off. Int. Epiz. 25, 961–979. 
Majer, J., Hornyák, Á., Ózsvári, L., Bárdos, K. and Szabára, Á. (2014): BVDV infection of a large-
scale diary cattle herd during grazing [in Hungarian, with English abstract]. Magyar Állat-
orvosok Lapja 136, 277–285. 
Orban, S., Liess, B., Hafez, S. M., Frey, H. R., Blindow, H. and Sasse-Patzer, B. (1983): Studies on 
transplacental transmissibility of a Bovine Virus Diarrhoea (BVD) vaccine virus. I. Inocu-
lation of pregnant cows 15 to 90 days before parturition (190th to 265th day of gestation). 
Zbl. Vet. Med. B 30, 619–634. 
Ózsvári, L., Bíró, O. and Csaba, I. B. (2001): Quantification of losses caused by bovine viral diar-
rhoea and mucosal disease [in Hungarian, with English abstract]. Magyar Állatorvosok 
Lapja 123, 555–560. 
Radostits, O. M. and Done, S. H. (2007): Veterinary Medicine: A Textbook of the Diseases of Cat-
tle, Sheep, Pigs, Goats, and Horses. 10th edition. Elsevier Saunders, New York. 
Ridpath, J. F. (2010): Bovine Viral Diarrhea Virus: Global status. Vet. Clin. North Am. Food 
Anim. Pract. 26, 105–121. 
Szabára, Á. and Ózsvári, L. (2013): The prevalence, economic losses and eradication programs of 
BVDV in Europe [in Hungarian, with English abstract]. Magyar Állatorvosok Lapja 135, 
285–292. 
Vilcek, S., Mojzisova, J., Bajova, V., Paulik, S., Strojny, L., Durkovic, B. and Hipikova, V. (2003): 
A survey for BVDV antibodies in cattle farms in Slovakia and genetic typing of BVDV 
isolates from imported animals. Acta Vet. Hung. 51, 229–236. 
